Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. [electronic resource]
Producer: 20110112Description: 2241-6 p. digitalISSN:- 1549-4713
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Carcinoma in Situ -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Conjunctiva
- Conjunctival Neoplasms -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Injections
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Recombinant Proteins
- Retreatment
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.